Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Papa

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
European Journal of Cancer & Clinical Oncology|September 1, 1982
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)G Papa, F Mandelli, A P Anselmo, et al.
Leukemia & Lymphoma|January 1, 1995
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot studyA Venditti, M T Scimò, G del Poeta, et al.
Cancer Genetics and Cytogenetics|January 1, 1995
First report of t(8;21)(q22;q22) in a case of de novo acute monoblastic leukemiaM C Cox-Froncillo, M Genuardi, J Bajer, et al.
Blood|January 1, 1996
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implicationsA Venditti, G Del Poeta, R Stasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric studyG Cimino, G Papa, S Tura, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspectiveP Mazza, S Tura, M Bocchia, et al.
Blood|March 1, 1996
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, R Stasi, G Aronica, et al.
British Journal of Haematology|June 1, 1988
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effectJ F Apperley, F R Mauro, J M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's diseaseG Cimino, G P Biti, A P Anselmo, et al.
Haematologica|April 1, 1977
Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanineF Mandelli, S Amadori, A M De Luca, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
European Journal of Cancer & Clinical Oncology|September 1, 1982
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)G Papa, F Mandelli, A P Anselmo, et al.
Leukemia & Lymphoma|January 1, 1995
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot studyA Venditti, M T Scimò, G del Poeta, et al.
Cancer Genetics and Cytogenetics|January 1, 1995
First report of t(8;21)(q22;q22) in a case of de novo acute monoblastic leukemiaM C Cox-Froncillo, M Genuardi, J Bajer, et al.
Blood|January 1, 1996
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implicationsA Venditti, G Del Poeta, R Stasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric studyG Cimino, G Papa, S Tura, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspectiveP Mazza, S Tura, M Bocchia, et al.
Blood|March 1, 1996
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, R Stasi, G Aronica, et al.
British Journal of Haematology|June 1, 1988
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effectJ F Apperley, F R Mauro, J M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's diseaseG Cimino, G P Biti, A P Anselmo, et al.
Haematologica|April 1, 1977
Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanineF Mandelli, S Amadori, A M De Luca, et al.
Pageof 22